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Background: Many individuals with Ehlers-Danlos Syndrome (EDS) are hypermobile, suffer from long term pain,
and have complex health problems. Since these sometimes have no objective physical signs, individuals with EDS
sometimes are referred for psychiatric evaluation. The aim was therefore to identify the level of anxiety and quality
of life in a Swedish group of individuals with EDS.
Methods: A postal survey in 2008 was distributed to 365 members over 18 years of the Swedish National EDS
Association and 250 with EDS diagnosis responded. Two questionnaires, the Hospital Anxiety and Depression Scale
(HADS) and SF-36, were used. A Swedish population study was used to compare results from SF-36. Independent
Student’s t-test was used to compare differences between groups, possible relationships were tested using Spearman’s
correlation coefficient and the General Linear Model was used for regression analyses. Higher scores on HADS represent
higher levels of anxiety and depression and higher scores on SF-36 represent higher quality of health.
Results: Of the respondents 74.8% scored high on anxiety and 22.4% scored high on depression on the HADS. Age,
tiredness and back pain was independently associated with the HAD anxiety score in a multiple regression analysis, When
comparing the SF-36 scores from the EDS group and a Swedish population group, the EDS group scored significantly
lower, indicating lower health-related quality of health than the general population (p < 0.001).
Conclusions: In comparison with a Swedish population group, a lower health-related quality of life was found in the EDS
group. Also, higher levels of anxiety and depression were detected in individuals with EDS. The importance to explore the
factors behind these results and what initiatives can be taken to alleviate the situation for this group is emphasized.
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Ehlers-Danlos syndrome (EDS) is an inherited, lifelong
and potentially disabling connective tissue disorder. The
prominent features of this disorder are skin laxity, joint
hypermobility, chronic joint and limb pain, blood vessel
and tissue fragility [1,2]. A phenotypic variance in individ-
uals, from milder to serious presentations with different
sets of symptoms, is a problem for the physician when
clarifying the diagnosis, such as to clarify the patient’s type
of EDS. Six different EDS-types are suggested based on
clinical features, genetic and biochemical grounds. The* Correspondence: briber30@gmail.com
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unless otherwise stated.types are called the classical type, the hyper mobile type,
the vascular type, the dermatosparaxis type, the arthrocha-
lasia type, and the kyphoscoliotic type [1].
Many aspects of life are affected by the disorder and
chronic pain restricts both physical and psychosocial
functions [3,4]. When comparing results from Subjective
Health Complaints (SHC) in this group with that of the
general Norwegian population, the EDS group scored
higher than the population on tiredness and chronic pain
[4]. The most reported complaints were musculoskeletal
and pseudo neurological, followed by gastroenterological
complaints [4]. Daily living is complicated by other symp-
toms as oral problems such as bleeding gums, dental loss,
oral pain, difficulty to chew and ineffective anesthetic in
treatment [5]. The relation between joint hypermobilityal. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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studied [6-8]. In comparison with controls, it was found
that panic disorder, agoraphobia, and simple phobia were
highly associated with JHS. Individuals with hypermobile
joints had significantly higher intensity of fears. The re-
searchers thus concluded that JHS and anxiety are related,
even in subjects with no psychiatric disorder [7].
In Sweden a number of EDS individuals have joined a
patient group, the National EDS Association. Many in-
dividuals in the EDS group have complex health prob-
lems, are hypermobile and suffer from chronic pain [9].
Since they sometimes don’t have observable physical
signs, individuals with EDS often feel humiliated when
their problems are neglected by health-care staff [10].
These persons feel invisible in health-care and often
struggle for many years to find a physician with whom
to discuss their problems. The aim was therefore to
identify perceived health-related quality of life and the




A postal survey was carried out in 2008 when adult individ-
uals over 18 years (n = 365), all being members of the
Swedish National Ehlers-Danlos Syndrome Association,
were invited to participate in the study. In the information
form was emphasized that responding to the questionnaires
was their consent to participate. Results from a randomized
Swedish population study were used to compare the SF-36
results from the EDS group.
Questionnaires
Information was retrieved about age, EDS type, body
weight, body height, current cigarette smoking (no/yes),
tiredness (no/yes/moderate/severe), current pain presence
in the cervical (no/yes), thoracic (no/yes) or sacral regions
(no/yes) were retrieved. A back pain variable was created as
the sum of cervical, thoracic and sacral regions, ranging
from 0 to 3, with 0 meaning no reported back pain.
To measure health related quality of life the Short form
Health Survey (SF-36) was used. The SF-36 is a well vali-
dated self-rating questionnaire where dimensions of health
are assessed, each ranging from 0-100 [11]. Low scores
represent low health-related quality of life. With 36 items
the following eight dimensions of functioning are de-
scribed: Physical Functioning, Physical Role Limitation,
Bodily Pain, General Health, Vitality, Social Functioning,
Emotional Role Limitation, and Mental Health. The reli-
ability and the validity of the Swedish SF-36 version is
tested and found satisfactory [12].
The Hospital Anxiety and Depression Scale (HADS) [13]
was used to assess levels of anxiety and depression. This
self-reported 14-item scale is divided in two dimensions:anxiety (seven items) and depression (seven items). The re-
sponses are marked on a Likert scale from zero to four.
The responses are summed within dimensions and a total
score for each dimension is calculated. The scores can be
categorized as follows: 0-7 indicates no anxiety/depression;
8-10 indicates possible anxiety/depression; 11-21 indicates
a probable case of anxiety/depression. Higher scores repre-
sent higher levels of anxiety and depression. The HADS is
found to be sensitive to somatic, psychiatric and primary
care patients as well in general population [14].
Statistical analysis
Summary statistics were computed using standard
methods. The Independent Student’s t-test was used to
compare differences between groups and the compari-
son between SF-36 scores was performed between the
EDS group and a population group of randomly se-
lected Swedish women and men (n = 8903) (12). Pos-
sible relationships based on ordinal data were tested
using Spearman’s correlation coefficient. The General
Linear Model was used for regression analyses. The
scale assigned for categorization of nominal and ordinal
factors used in the regression analyses was: female sex
(yes/no), current smoking (no/yes), tiredness (0/1/2/3)
and back pain (0 to 3). Only two-tailed tests were used.
A significance level of 0.05 was considered statistically
significant. Statistical analyses were performed using
the SAS program package version 9.3 (SAS Institute,
Cary, NC).




Completed questionnaires were returned by 250 individuals
with diagnosis (mean age 46.15; SD 12; range 18-84). 38%
of these were individuals with EDS but where the type of
EDS not was stated by the physician. The overall response
rate was 73%. There were 223 female respondents (89%)
and 27 males (11%). A high percentage (80%) reported
current smoking. The most frequent EDS variant (38%)
was the one where the specific type was not defined, the
hypermobility type was as well a common type (30%)
(Table 1).
Short Form health survey (SF-36)
The dimensions Physical Role Limitation, Bodily pain,
General Health and Vitality were rated as the lowest and
Mental Health as the highest. The mean Physical compo-
nent Score (PCS) of 26.0 (CI 24.6 to 27.4) in women and
37.2 (CI 32.4 to 42.0) in men were significantly different
(p < 0.0001). The mean Mental component Score (MCS)
of 41.5 (CI 39.9 to 43.1) in women and 47.3 (CI 42.3 to
52.4) in men were significantly different (p < 0.03). When





Age (years) 46.1 44.5 to 47.7














27.2 25.8 to 28.6
Mental component
score
42.1 40.6 to 43.6
Tiredness 234 (94)
Back pain Cervical region 204 (82)




Any back region 234 (94)
CI = 95% confidence interval.
Presented as mean, number and 95% confidence interval.
Table 3 The Hospital Anxiety and Depression scale
(HADS) with the compounds anxiety and depression
Score Mean 95 % C.I.
Anxiety Total score 12.0 11.7 to 12.4
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Swedish population group (12), the EDS group reported
significantly lower scores, 23.8 to 65 in the EDS group
as compared to 68.8 to 88.69 in the population group,
indicating lower quality of health than the population
group (Table 2).Table 2 Mean (CI) SF-36 scores in individuals with
Ehlers-Danlos’ syndrome (EDS) (n = 250) and a reference









48.3 (45.3 to 51.5) 87.9 .000
Physical Role
Limitation
23.8 (19.4 to 28.2) 83.2 .000
Bodily Pain 31.6 (29.1 to 34.9) 74.8 .000
General Health 34.2 (31.7 to 37.1) 75.8 .000
Vitality 30.2 (27.8 to 33.0) 68.8 .000
Social Functioning 53.7 (50.4 to 57.4) 88.6 .000
Emotional Role
Limitation
58.3 (53.4 to 64.1) 85.7 .000
Mental Health 65.5 (63.0 to 67.9) 80.9 .000Hospital Anxiety and Depression Scale (HADS)
The mean anxiety score was 12.0 (CI 11.7 to 12.4) and
the mean depression score 9.1 (CI 8.9 to 9.4) (Table 3).
The mean anxiety score of 13.1 among men was higher
than the score of 11.9 among women (p = 0.26). No dif-
ference was shown among the sexes regarding the
mean depression scores (p = 0.26). There was a weak
negative correlation between anxiety and depression
scores (rs = -0.13, p = 0.04 (Table 4). Probable anxiety
was rated by 74.8% and probable depression was rated
by 22.4% of the participants (Table 4). The items ‘sud-
den feelings of panic’ and ‘feeling as if something bad
will happen’ were rated as the highest of the anxiety
measures. ‘I feel cheerful’ and ‘I have lost interest in my
appearance’ were rated as the highest in the depression
measures (Table 3).
Associations between characteristic factors and HAD-score
To find possible factors associated with reported HAD-
scores simple and multiple regression analyses were
performed. The characteristics of the EDS individuals
were used as independent variables and the HAD
scores as the dependent variable. In the simple regres-
sion analyses, sex and age were positively associated
and tiredness and back pain were inversely associated
with HAD anxiety score. In the multiple regression
analysis age and tiredness were independently associated
with HAD anxiety score (Table 5). The R2 of the full
model was 0.11 (p < 0.0001). No associations between theI feel tense or wound up 1.9 1.8 to 2.0
Feeling as if something bad will
happen
2.0 1.9 to 2.1
Worrying thoughts 1.8 1.7 to 2.0
I can sit at ease and feel relaxed 1.3 1.2 to 1.4
Feeling like butterflies in the stomach 0.8 0.7 to 0.9
I feel restless 1.8 1.6 to 1.9
Sudden feelings of panic 2.4 2.3 to 2.5
Depression Total score 9.1 8.9 to 9.4
I enjoy things I used to enjoy 0.8 0.7 to 0.9
I can laugh and see funny things 0.6 0.5 to 0.7
I feel cheerful 2.3 2.2 to 2.4
I feel slowed down 1.6 1.4 to 1.7
I have lost interest in my appearance 2.2 2.1 to 2.3
I look forward with enjoyment 1.1 1.0 to 1.2
I can enjoy a book, radio or TV 0.7 0.6 to 0.8
Table 4 Sum of reported HAD-scores grouped three
categories (0-7 no anxiety/depression, 8-10 possible
anxiety/depression and 11-21 probable anxiety/
depression) among 250 individuals with Ehlers-Danlos’
syndrome
Sum of HAD-score Anxiety Depression
None 0-7 13 (5.2) 46 (18.4)
Possible 8-10 50 (20) 148 (59.2)
Probable 11-21 187 (74.8) 56 (22.4)
Number and proportion is presented.
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shown (data not shown). No collinearity problem was
shown (Vif <1.4).Discussion
Among individuals with Ehlers-Danlos syndrome symp-
toms of probable anxiety and depression were com-
monly reported as were tiredness and back pain. The
estimation of anxiety was three times higher than that of
depression. Tiredness and age were measured factors
that were independently and significantly associated with
anxiety in the EDS group. In addition, the EDS individ-
uals perceived their physical and mental health much
lower than a Swedish population group as measured
with SF-36.
The findings in this study significantly indicate the
perceived lower health-related quality of life in Swedish
individuals with EDS as compared with a Swedish popu-
lation group [12]. Different authors [6,8] have reported
that fears and anxiety are related to hypermobility of
joints. Findings that have hypermobile joints in focus are
interesting since many in the EDS group suffer from the
problems that hypermobility causes and strive to find
the reason for their health problems. Often these diffi-
culties are neglected by health care due to lack of know-
ledge of the consequences of hypermobile joints [10].Table 5 Associations between possible determinants and
sum of HADS depression and anxiety scores among
individuals with Ehlers-Danlos’ syndrome (n = 250)
Simple linear regression Multiple linear regression
R2 = 0.11, p < 0.0001
Variable Estimate R2 p= Estimate p=
Sex 0.85 0.01 0.16 0.01 0.98
Age (year) 0.03 0.02 0.03 0.03 0.07
Smoking 0.55 0.00 0.24 0.53 0.23
BMI (kg/m2) -0.07 0.02 0.03 -0.06 0.07
Tiredness -0.89 0.07 <0.0001 -0.65 0.002
Back pain -0.54 0.03 0.007 -0.12 0.30
BMI = body mass index.Women with EDS in the present study reported
poorer health-related quality of life than men. This may
be related to that women with EDS as well report more
subjective health complaints than men with EDS do [4].
In literature, tiredness or fatigue is observed as occur-
ring with pain, unrefreshing sleep and affective symp-
toms, which may imply a connection between the
underlying mechanisms [15]. That women in general re-
port more symptoms than men was also found in a
study by Loge and Kaasa [16] in Norway.
This study confirms earlier results that individuals
with EDS perceive a lower health-related quality of life
than the population. This can be related to different as-
pects, of which one might be food hypersensitivity, with
indigestion, itching and diarrhea as common problems
[17]. Individuals with EDS also report probable anxiety
and depression. Future research is encouraged to further
explore factors behind this and what initiatives can be
taken to find treatments to alleviate the situation for this
group is stressed.
Limitations
The major limitation in this study is that data are self-
reported due to that the respondents live in all parts of
the country. To independently confirm the diagnosis of
each person is therefore impossible, however, in the
background form a statement was made by each re-
spondent about having received the diagnosis by a
physician.
In addition, background variables were not compared
to that of the population group,
Clinical implications
Since probable anxiety and depression and lower health-
related quality was found in the present study in this
group of individuals with EDS, some implications for
health-care can be expected. Individuals in this group
may need more personal initiatives from health-care in
order to be able to manage daily life. Some suggestions
can be to learn about the daily consequences of EDS and
to acknowledge the physical and psychosocial differ-
ences. It is imperative to be aware of that this is a life-
long, genetic disease with no current treatment needs an
individual patient approach.
Conclusions
A considerably lower health-related quality of life was
found among EDS middle-aged individuals, in compari-
son with a Swedish population group. Also, probable
anxiety and depression were detected in individuals with
EDS. The importance to explore the factors behind these
results in research and what initiatives can be taken to
alleviate the situation for this group is emphasized.
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